World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN89530459
Date of registration: 12/09/2005
Prospective Registration: No
Primary sponsor: Vrije University Medical Centre (VUMC) (The Netherlands)
Public title: Fluorodeoxyglucose-positron emission tomography for avoidance of futile direct laryngoscopies under general anaesthesia with taking of biopsies in patients with suspicion on recurrent laryngeal carcinoma after radiotherapy
Scientific title:
Date of first enrolment: 01/02/2005
Target sample size: 150
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN89530459
Study type:  Interventional
Study design:  Randomised, active controlled, parallel group trial (Prevention)  
Phase: 
Countries of recruitment
Netherlands
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: R    de Bree
Address:  Boelelaan 1117 Department of Otolaryngology /Head and Neck Surgery Vrije University Medical Centre 1081 HV Amsterdam Netherlands
Telephone: +31 (0)20 444 3690
Email: r.bree@vumc.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Patients with clinical suspicion on recurrent laryngeal carcinoma after radiotherapy (without obvious signs of tumour), in whom a direct laryngoscopy under general anaesthesia with taking of biopsies is indicated
2. T2 - T4 laryngeal carcinoma

Exclusion criteria: 1. Aged less than 18 years
2. Pregnancy
3. Radiotherapy within the last four months


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Laryngeal carcinoma
Cancer
Laryngeal cancer
Intervention(s)
Selection for direct laryngoscopy with fluorodeoxyglucose-positron emission tomography (FDG-PET). Two strategy arms are compared:
1. Conventional strategy: direct laryngoscopy under general anaesthesia with taking of biopsies
2. PET based strategy: only direct laryngoscopy under general anaesthesia with taking of biopsies if FDG-PET is positive or equivocal
Primary Outcome(s)
Number of direct laryngoscopies (on a group level) needed to detect (a single) recurrent laryngeal carcinoma.
Secondary Outcome(s)
Key:
1. Costs
2. Operability of a recurrence
3. Surgical margins of the salvage laryngectomy
4. Quality of life
Secondary ID(s)
ZonMw: 945-04-311 2004/036 (projectnummer VUmc); NTR93
Source(s) of Monetary Support
The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history